Bronstein, Gewirtz & Grossman Files Class Action Against Insulet Alleging Securities Fraud

GlobeNewswire··Read original
2▲0 ▼1Impact / 5
Summary · why it matters

Bronstein, Gewirtz & Grossman, LLC has filed a class action lawsuit against Insulet Corporation and certain officers, alleging violations of federal securities laws. The suit seeks to recover damages for investors who purchased or acquired Insulet securities between May 21, 2025 and May 26, 2026. The complaint claims that defendants made materially false and misleading statements regarding the company's business, operations, and compliance policies, including defective manufacturing controls that created a heightened risk of safety violations or injury. Investors have until August 31, 2026 to seek lead plaintiff appointment. The law firm represents investors on a contingency fee basis.

Impact on assets 1

Biotech & Genomic Medicine▼ · 1 stocks
Insulet Corporation
PODD
▼ NegativeRegulationrelevance

Class action lawsuit alleging securities fraud and defective manufacturing controls.